XML 56 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

SCHEDULE OF DISAGGREGATED REVENUE

For the years ended December 31, 2023 and 2022, the Company had the following disaggregated revenue:

 SCHEDULE OF DISAGGREGATED REVENUE

		Year Ended December 31,
		2023				%				2022				%
Telehealth revenue (excluding collaboration revenue)		$	93,152,919				61	%		$	82,649,845				69	%
WorkSimpli revenue			54,394,087				36	%			36,383,675				31	%
Medifast collaboration revenue			5,000,000				3	%			-				-	%
Total net revenue		$	152,547,006				100	%		$	119,033,520				100	%

SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The Company expects to recognize $8.8 million of revenue during the year ended December 31, 2024 related to future performance obligations that are unsatisfied or partially unsatisfied as of December 31, 2023.

 SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

		2023				2022
		Year Ended December 31,
		2023				2022
Beginning of period		$	5,547,506			$	1,499,880
Additions			58,319,435				37,410,617
Revenue recognized			(55,038,343	)			(33,362,991	)
End of period		$	8,828,598			$	5,547,506

SUMMARY OF INVENTORY

As of December 31, 2023 and 2022, the Company’s inventory consisted of the following:

SUMMARY OF INVENTORY

		2023				2022
		December 31,
		2023				2022
Finished Goods - Products		$	1,898,784			$	2,587,370
Raw materials and packaging components			1,216,833				1,276,891
Inventory reserve			(355,685	)			(160,898	)
Total Inventory - net		$	2,759,932			$	3,703,363

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares:

 SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

		2023				2022
		Year Ended December 31,
		2023				2022
Series B Preferred Stock			-				1,404,868
RSUs and RSAs			3,556,375				1,743,250
Stock options			2,336,222				3,758,920
Warrants			4,730,607				3,859,638
Convertible long-term debt			671,141				-
Potentially dilutive securities			11,294,345				10,766,676

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483489/210-10-50-1

+ Details

Name:	us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration